Introduction and Objective: Virtual diabetes management platforms can be used to improve glycemic control for people with diabetes. The objective of this study was to evaluate the effectiveness of the Diabetes Care Management coaching program in the Wellworks for You© (WW) chronic disease management virtual platform.Methods: A cohort of people with diabetes enrolled in the WW Diabetes Management Program between Sept 2021-2024 were evaluated. At entry, participants completed a biometric screen including blood pressure, A1c, fasting glucose & lipids, and a diabetes distress questionnaire (DDQ). The DDQ was completed every 90 days. Participants entered home glucose levels and A1c into the WW platform. Coaching calls were with certified diabetes educators (CDEs). Main outcomes were change in A1c and DDQ score, stratified by number of calls completed.Results: Of the 651 people enrolled, 479 (74%) were female, 56% white, 14% Hispanic, 10% black. At entry, mean age was 49±13 years, BMI 34.4±8 kg/m2, BP 124±14/77±9 mmHg, HR 75±11, fasting glucose 128±53 mg/dL, TC 178±41 mg/dL, LDL 99±34 mg/dL, HDL 50±13 mg/dL, TG 153±94 mg/dL, A1c 7.4±1.7%, and DDQ score 51.0±12.1. Mean A1c decreased to 6.6±1.2% (Δ -0.8%). Mean DDQ score decreased to 47.4±12.6 (Δ -3.6). In those completing 2-4 coach calls, A1c decreased by -1.2% and DDS by -1.1. In those completing ≥5 coach calls, A1c decreased -1.8% and DDS -8.9. More contact with diabetes management coaches was associated with greater improvements in glycemic control and diabetes distress.Conclusion: Participants engaging with trained CDE coaches experience measurable improvements in health outcomes. Notably, those who completed ≥5 coaching sessions achieved a mean reduction in A1c of 1.8% compared to 1.2% with less participation. These results underscore the value of personalized coaching in managing diabetes and suggest that sustained engagement with coaching interventions can significantly enhance health metrics.
A.D. Coviello: Advisory Panel; Novo Nordisk. Consultant; Intuitive Surgical. Other Relationship; GI Dynamics. Consultant; Hanmi Pharm. Co., Ltd. Advisory Panel; NewAmsterdam Pharma. R. Fox: None. M. Wolf: None. T. Jones: None. R. Powers: None. C. Whitton: None.
Source link
Leave a Reply